Inventor · disambiguated record
Stefan Wawersik
Also filed as: WAWERSIK STEFAN
10 granted patents·8 pending applications·33 citations·filing 2017–2025
86Inventor score
Files withSCHOLAR ROCK INC18
Top patents by PatentIndex Score
18 records- 0194US12006359B2Methods for altering body composition by administering anti-pro/latent myostatin antibodiesSCHOLAR ROCK INC·Filed 2020·Granted Jun 11, 2024·3 cites·8 claims
- 0294US10287345B2Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodiesSCHOLAR ROCK INC·Filed 2017·Granted May 14, 2019·14 cites·11 claims
- 0391US10882904B2Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodiesSCHOLAR ROCK INC·Filed 2019·Granted Jan 5, 2021·6 cites·19 claims
- 0488US11214614B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2020·Granted Jan 4, 2022·2 cites·3 claims
- 0588US11155611B2Compositions and methods for making and using anti-myostatin antibodiesSCHOLAR ROCK INC·Filed 2018·Granted Oct 26, 2021·5 cites·7 claims
- 0686US11365245B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2021·Granted Jun 21, 2022·1 cites·8 claims
- 0785US12122823B2Isoform-selective TGFB1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Granted Oct 22, 2024·1 cites·13 claims
- 0883US2024391989A1Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodiesSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 0982US2025179164A1LTBP COMPLEX-SPECIFIC INHIBITORS OF TGFb AND USES THEREOFSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 1077US11130803B2Isoform-selective TGFβ1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 1177US2025215072A1Isoform-selective tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 1275US12173059B2LTBP complex-specific inhibitors of TGFβ and uses thereofSCHOLAR ROCK INC·Filed 2022·Granted Dec 24, 2024·0 cites·20 claims
- 1364US2022106390A1Methods for treating metabolic diseases by inhibiting myostatin activationSCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 1463US12252531B2Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitorsSCHOLAR ROCK INC·Filed 2019·Granted Mar 18, 2025·0 cites·5 claims
- 1558US2025257125A1HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2025·Application pending·0 cites
- 1651US2023057012A1Tgfb inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 1745US2021340238A1TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2019·Application pending·0 cites
- 1844US2020181251A1Lrrc33 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stefan Wawersik files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →